Edit
Shanghai Yingli Pharmaceutical Co., Ltd.
http://www.yl-pharma.com/en/Last activity: 11.12.2023
Investors 1
| Date | Name | Website |
| - | ShangPharm... | spiivc.com |
Mentions in press and media 4
| Date | Title | Description | Source |
| 11.12.2023 | Yingli Pharma presents a pivotal Phase 2 study data evaluati... | Linperlisib achieved Overall Response Rate of 48% with 30% being Complete Response and manageable sa... | en.prnasia... |
| 09.11.2022 | Yingli Pharma Announces NMPA Approval of New Anti-cancer Dru... | The first highly selective PI3Kδ inhibitor in China SHANGHAI, CHINA – Media OutReach – 9 November 2... | africanews... |
| 11.06.2021 | Yingli Pharma Announces a presentation on the Phase 2 clinic... | SHANGHAI, June 11, 2021 /PRNewswire/ -- Shanghai Yingli Pharmaceuticals Ltd (Yingli Pharma), a clini... | en.prnasia... |
| 04.06.2021 | Yingli Pharma Announces presentations on the Phase 1 trials ... | Clinical trial data will be updated in three presentations on lead drug candidates Linperlisib, a po... | en.prnasia... |